All Updates

All Updates

icon
Filter
M&A
HOPE Therapeutics to acquire interventional psychiatry clinics in Florida to expand network
Psychedelic Medicine
Oct 30, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Psychedelic Medicine

Psychedelic Medicine

Oct 30, 2024

HOPE Therapeutics to acquire interventional psychiatry clinics in Florida to expand network

M&A

  • HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, has signed a non-binding letter of intent to acquire interventional psychiatry clinics in Florida.

  • The acquisition is expected to be immediately accretive to revenue and EBITDA for HOPE and NRx Pharmaceuticals. The company plans to work with the founders to optimize additional acquisitions and establish HOPE as a model for clinics, providing a standard of care for central nervous system disorders.

  • Analyst QuickTake: HOPE Therapeutics is expanding its network of clinics offering ketamine therapy and other treatments. Earlier this month , it acquired a leading West Coast interventional psychiatric clinic and in August 2024 , it purchased five interventional psychiatry clinics for USD 30 million, reinforcing its presence in this growing field.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.